Friess Associates’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-93,498
Closed -$3.16M – 114
2019
Q2
$3.16M Sell
93,498
-500,000
-84% -$16.2M 0.23% 95
2019
Q1
$19M Buy
593,498
+183,698
+45% +$5.65M 1.4% 27
2018
Q4
$12.9M Buy
409,800
+404,800
+8,096% +$13.3M 1.1% 48
2018
Q3
$174K Buy
+5,000
New +$176K 0.01% 116

Other funds holding ELAN

Friess Associates's ELAN Position: Q3 2019 in Review

Friess Associates sold out of Elanco Animal Health (ELAN) in Q3 2019, closing a stake of 93,498 shares — an estimated $3.16M sold.

Friess Associates first reported a position in ELAN in Q3 2018 and held it in 4 quarters. The position peaked at $19M in Q1 2019. 376 funds tracked by Wall St. Rank hold ELAN as of Q3 2019.

  • Friess Associates reported no remaining Elanco Animal Health position as of Q3 2019 after selling out during the quarter.
  • Friess Associates sold 93,498 Elanco Animal Health shares in Q3 2019, an estimated $3.16M.
  • Friess Associates first reported a position in Elanco Animal Health in Q3 2018 and held it in 4 quarters.
  • Friess Associates's Elanco Animal Health position peaked at $19M in Q1 2019.
  • 376 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2019.

Based on Friess Associates's 13F filing for Q3 2019, filed 14 Nov 2019.